 Anavex Life Sciences Corp AVXL reported topline data from the Phase 3 AVATAR trial of ANAVEX2-73 blarcamesine in adult female patients with Rett syndrome. LIVE NOW ON YOUTUBE Click Here to Watch a FREE MASTERCLASS on the Ultimate Bear Market Survival Guide with Matt Maley! 